Introduktion
Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Casey M Tansey. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.
Gennemsnitlig handelsrentabilitet
Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.
Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.
Opdateringsfrekvens: Dagligt
Virksomheder med rapporterede insider-stillinger
SEC-registreringen viser, at Casey M Tansey har rapporteret besiddelser eller handler i følgende virksomheder:
Sikkerhed | Titel | Senest indberettede beholdninger |
---|---|---|
Director | 16.447 | |
Director, 10% Owner | 47.666 | |
10% Owner | 1.117.743 | |
US:INSP / Inspire Medical Systems, Inc. | Director | 22.014 |
US:EFTR / eFFECTOR Therapeutics, Inc. | 10% Owner | 127.569 |
US:ONTF / ON24, Inc. | 10% Owner | 45.505 |
US:NARI / Inari Medical, Inc. | 10% Owner | 242.988 |
US:SBTX / Silverback Therapeutics Inc | 10% Owner | 0 |
US:IMI / Intermolecular, Inc. | 10% Owner | 97.593 |
US:BOX / Box, Inc. | 10% Owner | 3.713.775 |
US:XENT / Intersect ENT Inc | Director | 6.035 |
US:CSLT / Castlight Health Inc - Class B | 10% Owner | 0 |
US:OMED / OptMed Inc | 10% Owner | 56.528 |
US:GWRE / Guidewire Software, Inc. | 10% Owner | 36.638 |
US:MXL / MaxLinear, Inc. | 10% Owner | 10.969 |
US:ATRC / AtriCure, Inc. | 10% Owner | 11.873 |
Sådan fortolkes diagrammerne
Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Casey M Tansey. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.
I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.
Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.
Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.
Insiderkøb ATRC / AtriCure, Inc. – kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ATRC / AtriCure, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Handelsdato | Ticker | Insider | Rapporteret Aktier |
Rapporteret Pris |
Justeret Aktier |
Justeret Pris |
Omkostningsgrundlag | dage til Maks |
Pris kl Maks |
Maks Fortjeneste ($) |
Maks. afkast (%) |
---|---|---|---|---|---|---|---|
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination |
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insidersalg ATRC / AtriCure, Inc. – kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ATRC / AtriCure, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
Handelsdato | Ticker | Insider | Rapporteret Aktier |
Rapporteret Pris |
Justeret Aktier |
Justeret Pris |
Omkostningsgrundlag | dage til Min |
Pris kl Min |
Max tab Undgået ($) |
Max tab Undgået (%) |
---|---|---|---|---|---|---|---|
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination |
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insiderkøb BOX / Box, Inc. – kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ATRC / AtriCure, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Handelsdato | Ticker | Insider | Rapporteret Aktier |
Rapporteret Pris |
Justeret Aktier |
Justeret Pris |
Omkostningsgrundlag | dage til Maks |
Pris kl Maks |
Maks Fortjeneste ($) |
Maks. afkast (%) |
---|---|---|---|---|---|---|---|
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination |
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insidersalg BOX / Box, Inc. – kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ATRC / AtriCure, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
Handelsdato | Ticker | Insider | Rapporteret Aktier |
Rapporteret Pris |
Justeret Aktier |
Justeret Pris |
Omkostningsgrundlag | dage til Min |
Pris kl Min |
Max tab Undgået ($) |
Max tab Undgået (%) |
---|---|---|---|---|---|---|---|
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination |
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insiderkøb EFTRW / eFFECTOR Therapeutics, Inc. - Equity Warrant – kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ATRC / AtriCure, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Handelsdato | Ticker | Insider | Rapporteret Aktier |
Rapporteret Pris |
Justeret Aktier |
Justeret Pris |
Omkostningsgrundlag | dage til Maks |
Pris kl Maks |
Maks Fortjeneste ($) |
Maks. afkast (%) |
---|---|---|---|---|---|---|---|
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination |
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insidersalg EFTRW / eFFECTOR Therapeutics, Inc. - Equity Warrant – kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ATRC / AtriCure, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insiderkøb INSP / Inspire Medical Systems, Inc. – kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ATRC / AtriCure, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Handelsdato | Ticker | Insider | Rapporteret Aktier |
Rapporteret Pris |
Justeret Aktier |
Justeret Pris |
Omkostningsgrundlag | dage til Maks |
Pris kl Maks |
Maks Fortjeneste ($) |
Maks. afkast (%) |
---|---|---|---|---|---|---|---|---|---|---|---|
2018-05-07 | INSP | Tansey Casey M | 187.500 | 16,0000 | 187.500 | 16,0000 | 3.000.000 | 297 | 62 | 8.625.000 | 287,50 |
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insidersalg INSP / Inspire Medical Systems, Inc. – kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ATRC / AtriCure, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insiderkøb MXL / MaxLinear, Inc. – kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ATRC / AtriCure, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Handelsdato | Ticker | Insider | Rapporteret Aktier |
Rapporteret Pris |
Justeret Aktier |
Justeret Pris |
Omkostningsgrundlag | dage til Maks |
Pris kl Maks |
Maks Fortjeneste ($) |
Maks. afkast (%) |
---|---|---|---|---|---|---|---|
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination |
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insidersalg MXL / MaxLinear, Inc. – kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ATRC / AtriCure, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
Handelsdato | Ticker | Insider | Rapporteret Aktier |
Rapporteret Pris |
Justeret Aktier |
Justeret Pris |
Omkostningsgrundlag | dage til Min |
Pris kl Min |
Max tab Undgået ($) |
Max tab Undgået (%) |
---|---|---|---|---|---|---|---|
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination |
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insiderkøb ONTF / ON24, Inc. – kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ATRC / AtriCure, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Handelsdato | Ticker | Insider | Rapporteret Aktier |
Rapporteret Pris |
Justeret Aktier |
Justeret Pris |
Omkostningsgrundlag | dage til Maks |
Pris kl Maks |
Maks Fortjeneste ($) |
Maks. afkast (%) |
---|---|---|---|---|---|---|---|---|---|---|---|
2021-02-05 | ONTF | PRESIDIO MANAGEMENT GROUP VII L L C | 5.000 | 50,0000 | 5.000 | 50,0000 | 250.000 | 4 | 74.5 | 122.500 | 49,00 |
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insidersalg ONTF / ON24, Inc. – kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ATRC / AtriCure, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insiderkøb SPRY / ARS Pharmaceuticals, Inc. – kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ATRC / AtriCure, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Handelsdato | Ticker | Insider | Rapporteret Aktier |
Rapporteret Pris |
Justeret Aktier |
Justeret Pris |
Omkostningsgrundlag | dage til Maks |
Pris kl Maks |
Maks Fortjeneste ($) |
Maks. afkast (%) |
---|---|---|---|---|---|---|---|---|---|---|---|
2020-12-08 | SBTX | Presidio Management Group XII, L.L.C. | 47.619 | 21,0000 | 47.619 | 21,0000 | 999.999 | 99 | 60.41 | 1.876.665 | 187,67 |
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insidersalg SPRY / ARS Pharmaceuticals, Inc. – kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ATRC / AtriCure, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
Handelsdato | Ticker | Insider | Rapporteret Aktier |
Rapporteret Pris |
Justeret Aktier |
Justeret Pris |
Omkostningsgrundlag | dage til Min |
Pris kl Min |
Max tab Undgået ($) |
Max tab Undgået (%) |
---|---|---|---|---|---|---|---|
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination |
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insiderhandelshistorie
Denne tabel viser den komplette liste over insiderhandler foretaget af Casey M Tansey som oplyst til Securities Exchange Commission (SEC).
Fil dato | Transdato | Form | Ticker | Sikkerhed | Kode | Aktier | Resterende aktier | Procent Lave om |
Del Pris |
Tran Værdi |
Tilbage Værdi |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-08-11 |
|
4 | HTFL |
Heartflow, Inc.
Common Stock |
C - Conversion | 16.447 | 16.447 | |||||
2025-08-11 |
|
4 | HTFL |
Heartflow, Inc.
Common Stock |
C - Conversion | 98.303 | 98.303 | |||||
2025-08-11 |
|
4 | HTFL |
Heartflow, Inc.
Common Stock |
C - Conversion | 3.072.759 | 3.072.759 | |||||
2025-08-05 |
|
4 | SI |
SHOULDER INNOVATIONS, INC.
Common Stock |
P - Purchase | 40.000 | 47.666 | 521,78 | 15,00 | 600.000 | 714.990 | |
2025-08-05 |
|
4 | SI |
SHOULDER INNOVATIONS, INC.
Common Stock |
A - Award | 7.666 | 7.666 | |||||
2025-08-05 |
|
4 | SI |
SHOULDER INNOVATIONS, INC.
Common Stock |
C - Conversion | 921.131 | 921.131 | |||||
2025-08-05 |
|
4 | SI |
SHOULDER INNOVATIONS, INC.
Common Stock |
C - Conversion | 85.587 | 85.587 | |||||
2025-08-05 |
|
4 | SI |
SHOULDER INNOVATIONS, INC.
Common Stock |
C - Conversion | 1.686.403 | 1.686.403 | |||||
2025-07-24 |
|
4 | CARL |
CARLSMED, INC.
Common Stock |
C - Conversion | 1.117.743 | 1.117.743 | |||||
2025-07-24 |
|
4 | CARL |
CARLSMED, INC.
Common Stock |
C - Conversion | 26.993 | 218.524 | 14,09 | ||||
2025-07-24 |
|
4 | CARL |
CARLSMED, INC.
Common Stock |
C - Conversion | 41.876 | 191.531 | 27,98 | ||||
2025-07-24 |
|
4 | CARL |
CARLSMED, INC.
Common Stock |
C - Conversion | 149.655 | 149.655 | |||||
2025-07-24 |
|
4 | CARL |
CARLSMED, INC.
Common Stock |
C - Conversion | 531.877 | 4.305.806 | 14,09 | ||||
2025-07-24 |
|
4 | CARL |
CARLSMED, INC.
Common Stock |
C - Conversion | 825.135 | 3.773.929 | 27,98 | ||||
2025-07-24 |
|
4 | CARL |
CARLSMED, INC.
Common Stock |
C - Conversion | 2.948.794 | 2.948.794 | |||||
2025-07-16 |
|
4 | INSP |
Inspire Medical Systems, Inc.
Common Stock |
A - Award | 133 | 22.014 | 0,61 | 128,00 | 17.024 | 2.817.792 | |
2025-05-05 |
|
4 | INSP |
Inspire Medical Systems, Inc.
Common Stock |
A - Award | 1.266 | 21.881 | 6,14 | ||||
2025-04-16 |
|
4 | INSP |
Inspire Medical Systems, Inc.
Common Stock |
A - Award | 103 | 20.615 | 0,50 | 149,70 | 15.419 | 3.086.066 | |
2025-01-17 |
|
4 | INSP |
Inspire Medical Systems, Inc.
Common Stock |
A - Award | 81 | 20.512 | 0,40 | 176,33 | 14.283 | 3.616.881 | |
2024-10-16 |
|
4 | INSP |
Inspire Medical Systems, Inc.
Common Stock |
A - Award | 68 | 20.431 | 0,33 | 210,46 | 14.311 | 4.299.908 | |
2024-07-17 |
|
4 | INSP |
Inspire Medical Systems, Inc.
Common Stock |
A - Award | 103 | 20.363 | 0,51 | 138,58 | 14.274 | 2.821.905 | |
2024-05-06 |
|
4 | INSP |
Inspire Medical Systems, Inc.
Common Stock |
A - Award | 716 | 20.260 | 3,66 | ||||
2024-04-16 |
|
4 | INSP |
Inspire Medical Systems, Inc.
Common Stock |
A - Award | 62 | 19.544 | 0,32 | 231,74 | 14.368 | 4.529.127 | |
2024-01-18 |
|
4 | INSP |
Inspire Medical Systems, Inc.
Common Stock |
A - Award | 77 | 19.482 | 0,40 | 186,10 | 14.330 | 3.625.600 | |
2024-01-18 |
|
4 | INSP |
Inspire Medical Systems, Inc.
Common Stock |
A - Award | 8 | 19.405 | 0,04 | 150,47 | 1.204 | 2.919.870 | |
2024-01-18 |
|
4 | INSP |
Inspire Medical Systems, Inc.
Common Stock |
A - Award | 2 | 19.397 | 0,01 | 325,91 | 652 | 6.321.676 | |
2024-01-18 |
|
4 | INSP |
Inspire Medical Systems, Inc.
Common Stock |
G - Gift | 500 | 500 | |||||
2024-01-18 |
|
4 | INSP |
Inspire Medical Systems, Inc.
Common Stock |
G - Gift | 500 | 500 | |||||
2024-01-18 |
|
4 | INSP |
Inspire Medical Systems, Inc.
Common Stock |
G - Gift | -500 | 19.395 | -2,51 | ||||
2024-01-18 |
|
4 | INSP |
Inspire Medical Systems, Inc.
Common Stock |
G - Gift | -500 | 19.395 | -2,51 | ||||
2023-10-17 |
|
4 | INSP |
Inspire Medical Systems, Inc.
Common Stock |
A - Award | 87 | 20.395 | 0,43 | 150,47 | 13.091 | 3.068.836 | |
2023-07-19 |
|
4 | INSP |
Inspire Medical Systems, Inc.
Common Stock |
A - Award | 40 | 20.308 | 0,20 | 325,91 | 13.036 | 6.618.580 | |
2023-05-01 |
|
4 | INSP |
Inspire Medical Systems, Inc.
Common Stock |
A - Award | 669 | 20.268 | 3,41 | ||||
2023-04-12 |
|
4 | INSP |
Inspire Medical Systems, Inc.
Common Stock |
A - Award | 56 | 19.599 | 0,29 | 231,77 | 12.979 | 4.542.460 | |
2023-01-19 |
|
4 | INSP |
Inspire Medical Systems, Inc.
Common Stock |
A - Award | 52 | 19.543 | 0,27 | 248,31 | 12.912 | 4.852.722 | |
2022-10-13 |
|
4 | INSP |
Inspire Medical Systems, Inc.
Common Stock |
A - Award | 81 | 19.491 | 0,42 | 168,98 | 13.687 | 3.293.589 | |
2022-08-03 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -1.796 | 127.569 | -1,39 | 0,80 | -1.444 | 102.565 | |
2022-08-03 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -57.580 | 3.981.940 | -1,43 | 0,80 | -46.294 | 3.201.480 | |
2022-08-03 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -853 | 129.365 | -0,66 | 0,80 | -680 | 103.104 | |
2022-08-03 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -27.348 | 4.039.520 | -0,67 | 0,80 | -21.796 | 3.219.497 | |
2022-08-03 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -807 | 130.218 | -0,62 | 0,79 | -634 | 102.351 | |
2022-08-03 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -25.896 | 4.066.868 | -0,63 | 0,79 | -20.354 | 3.196.558 | |
2022-07-29 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -984 | 131.025 | -0,75 | 0,89 | -878 | 116.874 | |
2022-07-29 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -31.533 | 4.092.764 | -0,76 | 0,89 | -28.127 | 3.650.745 | |
2022-07-27 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -1.321 | 132.009 | -0,99 | 0,89 | -1.178 | 117.752 | |
2022-07-27 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -42.344 | 4.124.297 | -1,02 | 0,89 | -37.771 | 3.678.873 | |
2022-07-27 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -84 | 133.330 | -0,06 | 0,90 | -76 | 120.530 | |
2022-07-27 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -2.691 | 4.166.641 | -0,06 | 0,90 | -2.433 | 3.766.643 | |
2022-07-27 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -69 | 133.414 | -0,05 | 0,93 | -64 | 124.208 | |
2022-07-27 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -2.210 | 4.169.332 | -0,05 | 0,93 | -2.058 | 3.881.648 | |
2022-07-22 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -231 | 133.483 | -0,17 | 0,91 | -210 | 121.603 | |
2022-07-22 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -7.383 | 4.171.542 | -0,18 | 0,91 | -6.719 | 3.796.103 | |
2022-07-22 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -81 | 133.714 | -0,06 | 0,96 | -77 | 127.831 | |
2022-07-22 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -2.584 | 4.178.925 | -0,06 | 0,96 | -2.468 | 3.990.873 | |
2022-07-22 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -304 | 133.795 | -0,23 | 1,00 | -304 | 133.929 | |
2022-07-22 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -9.726 | 4.181.509 | -0,23 | 1,00 | -9.736 | 4.185.691 | |
2022-07-19 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -84 | 134.099 | -0,06 | 1,00 | -84 | 134.099 | |
2022-07-19 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -2.670 | 4.191.235 | -0,06 | 1,00 | -2.670 | 4.191.235 | |
2022-07-19 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -635 | 134.183 | -0,47 | 1,08 | -686 | 145.052 | |
2022-07-19 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -20.352 | 4.193.905 | -0,48 | 1,08 | -21.980 | 4.529.417 | |
2022-07-19 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -1.423 | 134.818 | -1,04 | 1,11 | -1.577 | 149.378 | |
2022-07-19 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -44.477 | 4.214.257 | -1,04 | 1,11 | -49.281 | 4.669.397 | |
2022-07-13 |
|
4 | INSP |
Inspire Medical Systems, Inc.
Common Stock |
A - Award | 77 | 19.410 | 0,40 | 193,86 | 14.927 | 3.762.823 | |
2022-05-19 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -266 | 136.241 | -0,19 | 1,69 | -449 | 230.111 | |
2022-05-19 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -8.308 | 4.258.734 | -0,19 | 1,69 | -14.041 | 7.197.260 | |
2022-05-19 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -437 | 136.507 | -0,32 | 1,73 | -758 | 236.703 | |
2022-05-19 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -13.649 | 4.267.042 | -0,32 | 1,73 | -23.667 | 7.399.051 | |
2022-05-19 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -365 | 136.944 | -0,27 | 1,75 | -639 | 239.652 | |
2022-05-19 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -11.402 | 4.280.691 | -0,27 | 1,75 | -19.942 | 7.486.929 | |
2022-05-16 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -395 | 137.309 | -0,29 | 1,75 | -690 | 239.742 | |
2022-05-16 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -12.374 | 4.292.093 | -0,29 | 1,75 | -21.605 | 7.493.994 | |
2022-05-16 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -701 | 137.704 | -0,51 | 1,84 | -1.289 | 253.238 | |
2022-05-16 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -21.906 | 4.304.467 | -0,51 | 1,84 | -40.285 | 7.915.915 | |
2022-05-16 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -336 | 138.405 | -0,24 | 2,00 | -673 | 277.225 | |
2022-05-16 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -10.464 | 4.326.373 | -0,24 | 2,00 | -20.959 | 8.665.725 | |
2022-05-11 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -155 | 138.741 | -0,11 | 2,35 | -364 | 325.486 | |
2022-05-11 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -4.845 | 4.336.837 | -0,11 | 2,34 | -11.362 | 10.169.883 | |
2022-05-11 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -1.241 | 138.896 | -0,89 | 2,41 | -2.995 | 335.156 | |
2022-05-11 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -38.743 | 4.341.682 | -0,88 | 2,41 | -93.487 | 10.476.479 | |
2022-05-11 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -124 | 140.137 | -0,09 | 2,54 | -315 | 355.528 | |
2022-05-11 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -3.876 | 4.380.425 | -0,09 | 2,54 | -9.830 | 11.108.758 | |
2022-05-10 |
|
4 | INSP |
Inspire Medical Systems, Inc.
Stock Option (right to buy) |
A - Award | 1.243 | 1.243 | |||||
2022-04-12 |
|
4 | INSP |
Inspire Medical Systems, Inc.
Common Stock |
A - Award | 59 | 19.333 | 0,31 | 254,08 | 14.991 | 4.912.129 | |
2022-01-12 |
|
4 | INSP |
Inspire Medical Systems, Inc.
Common Stock |
A - Award | 65 | 19.274 | 0,34 | 227,56 | 14.791 | 4.385.991 | |
2021-12-06 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -252 | 140.261 | -0,18 | 5,68 | -1.431 | 796.682 | |
2021-12-06 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -7.861 | 4.384.301 | -0,18 | 5,68 | -44.650 | 24.902.830 | |
2021-12-01 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -597 | 140.513 | -0,42 | 6,44 | -3.843 | 904.482 | |
2021-12-01 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -18.648 | 4.392.162 | -0,42 | 6,44 | -120.037 | 28.272.347 | |
2021-12-01 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -850 | 141.110 | -0,60 | 6,53 | -5.553 | 921.872 | |
2021-12-01 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -26.559 | 4.410.810 | -0,60 | 6,53 | -173.483 | 28.811.411 | |
2021-12-01 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -799 | 141.960 | -0,56 | 6,70 | -5.349 | 950.422 | |
2021-12-01 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -24.965 | 4.437.369 | -0,56 | 6,70 | -167.141 | 29.708.185 | |
2021-11-26 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -156 | 142.759 | -0,11 | 7,01 | -1.093 | 1.000.455 | |
2021-11-26 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -4.870 | 4.462.334 | -0,11 | 7,01 | -34.148 | 31.289.886 | |
2021-11-26 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -1.132 | 142.915 | -0,79 | 7,36 | -8.326 | 1.051.140 | |
2021-11-26 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -35.388 | 4.467.204 | -0,79 | 7,36 | -260.279 | 32.856.285 | |
2021-11-26 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -461 | 144.047 | -0,32 | 7,40 | -3.413 | 1.066.524 | |
2021-11-26 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -14.418 | 4.502.592 | -0,32 | 7,40 | -106.736 | 33.332.689 | |
2021-11-22 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -812 | 144.508 | -0,56 | 7,86 | -6.382 | 1.135.833 | |
2021-11-22 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -25.371 | 4.517.010 | -0,56 | 7,86 | -199.416 | 35.503.699 | |
2021-11-22 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -224 | 145.320 | -0,15 | 8,12 | -1.819 | 1.179.998 | |
2021-11-22 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -7.017 | 4.542.381 | -0,15 | 8,12 | -56.985 | 36.888.676 | |
2021-11-22 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -519 | 145.544 | -0,36 | 8,53 | -4.426 | 1.241.199 | |
2021-11-22 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -16.226 | 4.549.398 | -0,36 | 8,53 | -138.375 | 38.797.266 | |
2021-11-17 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -317 | 146.063 | -0,22 | 9,13 | -2.894 | 1.333.263 | |
2021-11-17 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -9.918 | 4.565.624 | -0,22 | 9,13 | -90.522 | 41.670.450 | |
2021-11-17 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -257 | 146.380 | -0,18 | 9,42 | -2.421 | 1.378.900 | |
2021-11-17 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -8.062 | 4.575.542 | -0,18 | 9,42 | -75.936 | 43.097.030 | |
2021-11-17 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -157 | 146.637 | -0,11 | 9,81 | -1.540 | 1.438.362 | |
2021-11-17 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -4.914 | 4.583.604 | -0,11 | 9,81 | -48.211 | 44.969.739 | |
2021-11-12 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -372 | 146.794 | -0,25 | 10,07 | -3.746 | 1.478.216 | |
2021-11-12 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -11.628 | 4.588.518 | -0,25 | 10,07 | -117.094 | 46.206.376 | |
2021-11-12 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -373 | 147.166 | -0,25 | 10,37 | -3.867 | 1.525.817 | |
2021-11-12 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -11.644 | 4.600.146 | -0,25 | 10,37 | -120.725 | 47.694.314 | |
2021-11-12 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -1.054 | 147.539 | -0,71 | 10,44 | -11.000 | 1.539.717 | |
2021-11-12 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -32.946 | 4.611.790 | -0,71 | 10,44 | -343.824 | 48.128.640 | |
2021-11-12 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -893 | 148.593 | -0,60 | 11,00 | -9.827 | 1.635.117 | |
2021-11-12 |
|
4 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
S - Sale | -27.892 | 4.644.736 | -0,60 | 11,00 | -306.924 | 51.110.675 | |
2021-10-13 |
|
4 | INSP |
Inspire Medical Systems, Inc.
Common Stock |
A - Award | 64 | 19.209 | 0,33 | 231,04 | 14.787 | 4.438.047 | |
2021-08-27 | 3 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
3.981.940 | ||||||||
2021-08-27 | 3 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
127.389 | ||||||||
2021-08-27 | 3 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
690.688 | ||||||||
2021-08-27 | 3 | EFTR |
eFFECTOR Therapeutics, Inc.
Common Stock |
22.097 | ||||||||
2021-08-19 |
|
4 | ONTF |
ON24 INC.
Common Stock |
S - Sale | -15.625 | 45.505 | -25,56 | 20,03 | -312.969 | 911.465 | |
2021-08-19 |
|
4 | ONTF |
ON24 INC.
Common Stock |
S - Sale | -15.625 | 45.505 | -25,56 | 20,03 | -312.969 | 911.465 | |
2021-08-19 |
|
4 | ONTF |
ON24 INC.
Common Stock |
S - Sale | -312 | 0 | -100,00 | 20,03 | -6.249 | ||
2021-08-19 |
|
4 | ONTF |
ON24 INC.
Common Stock |
J - Other | 312 | 312 | |||||
2021-08-19 |
|
4 | ONTF |
ON24 INC.
Common Stock |
J - Other | -31.250 | 91.008 | -25,56 | ||||
2021-08-19 |
|
4 | ONTF |
ON24 INC.
Common Stock |
J - Other | -1.500.000 | 4.368.405 | -25,56 | ||||
2021-08-13 |
|
4 | ONTF |
ON24 INC.
Common Stock |
S - Sale | -15.625 | 61.130 | -20,36 | 21,20 | -331.250 | 1.295.956 | |
2021-08-13 |
|
4 | ONTF |
ON24 INC.
Common Stock |
S - Sale | -15.625 | 61.130 | -20,36 | 21,20 | -331.250 | 1.295.956 | |
2021-08-13 |
|
4 | ONTF |
ON24 INC.
Common Stock |
S - Sale | -312 | 0 | -100,00 | 21,20 | -6.614 | ||
2021-08-13 |
|
4 | ONTF |
ON24 INC.
Common Stock |
J - Other | 312 | 312 | |||||
2021-08-13 |
|
4 | ONTF |
ON24 INC.
Common Stock |
J - Other | -31.250 | 122.258 | -20,36 | ||||
2021-08-13 |
|
4 | ONTF |
ON24 INC.
Common Stock |
J - Other | -1.500.000 | 5.868.405 | -20,36 | ||||
2021-07-13 |
|
4 | INSP |
Inspire Medical Systems, Inc.
Common Stock |
A - Award | 78 | 19.145 | 0,41 | 185,73 | 14.487 | 3.555.801 | |
2021-05-03 |
|
4 | INSP |
Inspire Medical Systems, Inc.
Stock Option (right to buy) |
A - Award | 1.175 | 1.175 | |||||
2021-04-13 |
|
4 | INSP |
Inspire Medical Systems, Inc.
Common Stock |
A - Award | 62 | 19.067 | 0,33 | 218,45 | 13.544 | 4.165.186 | |
2021-03-18 |
|
4 | NARI |
Inari Medical, Inc.
Common Stock |
J - Other | 77.296 | 242.988 | 46,65 | ||||
2021-03-18 |
|
4 | NARI |
Inari Medical, Inc.
Common Stock |
J - Other | -685.827 | 0 | -100,00 | ||||
2021-03-18 |
|
4 | NARI |
Inari Medical, Inc.
Common Stock |
J - Other | 685.827 | 685.827 | |||||
2021-03-18 |
|
4 | NARI |
Inari Medical, Inc.
Common Stock |
J - Other | -83.814 | 83.813 | -50,00 | ||||
2021-03-18 |
|
4 | NARI |
Inari Medical, Inc.
Common Stock |
J - Other | -2.619.872 | 2.619.872 | -50,00 | ||||
2021-02-05 |
|
4 | ONTF |
ON24 INC.
Class A-2 Preferred Stock |
C - Conversion | -53.404 | 0 | -100,00 | ||||
2021-02-05 |
|
4 | ONTF |
ON24 INC.
Class A-2 Preferred Stock |
C - Conversion | -53.404 | 0 | -100,00 | ||||
2021-02-05 |
|
4 | ONTF |
ON24 INC.
Class A-2 Preferred Stock |
C - Conversion | -106.807 | 0 | -100,00 | ||||
2021-02-05 |
|
4 | ONTF |
ON24 INC.
Class A-2 Preferred Stock |
C - Conversion | -5.126.735 | 0 | -100,00 | ||||
2021-02-05 |
|
4 | ONTF |
ON24 INC.
Class A-1 Preferred Stock |
C - Conversion | -23.351 | 0 | -100,00 | ||||
2021-02-05 |
|
4 | ONTF |
ON24 INC.
Class A-1 Preferred Stock |
C - Conversion | -23.351 | 0 | -100,00 | ||||
2021-02-05 |
|
4 | ONTF |
ON24 INC.
Class A-1 Preferred Stock |
C - Conversion | -46.701 | 0 | -100,00 | ||||
2021-02-05 |
|
4 | ONTF |
ON24 INC.
Class A-1 Preferred Stock |
C - Conversion | -2.241.670 | 0 | -100,00 | ||||
2021-02-05 |
|
4 | ONTF |
ON24 INC.
Common Stock |
P - Purchase | 5.000 | 5.000 | 50,00 | 250.000 | 250.000 | ||
2021-02-05 |
|
4 | ONTF |
ON24 INC.
Common Stock |
C - Conversion | 76.755 | 76.755 | |||||
2021-02-05 |
|
4 | ONTF |
ON24 INC.
Common Stock |
C - Conversion | 76.755 | 76.755 | |||||
2021-02-05 |
|
4 | ONTF |
ON24 INC.
Common Stock |
C - Conversion | 153.508 | 153.508 | |||||
2021-02-05 |
|
4 | ONTF |
ON24 INC.
Common Stock |
C - Conversion | 7.368.405 | 7.368.405 | |||||
2021-01-21 |
|
4/A | NARI |
Inari Medical, Inc.
Common Stock |
J - Other | 67.730 | 165.692 | 69,14 | ||||
2021-01-12 |
|
4 | INSP |
Inspire Medical Systems, Inc.
Common Stock |
A - Award | 70 | 19.005 | 0,37 | 194,10 | 13.587 | 3.688.870 | |
2020-12-08 |
|
4 | SBTX |
Silverback Therapeutics, Inc.
Preferred Series C Stock |
C - Conversion | -54.496 | 0 | -100,00 | ||||
2020-12-08 |
|
4 | SBTX |
Silverback Therapeutics, Inc.
Preferred Series C Stock |
C - Conversion | -1.073.793 | 0 | -100,00 | ||||
2020-12-08 |
|
4 | SBTX |
Silverback Therapeutics, Inc.
Preferred Series B Stock |
C - Conversion | -335.417 | 0 | -100,00 | ||||
2020-12-08 |
|
4 | SBTX |
Silverback Therapeutics, Inc.
Preferred Series B Stock |
C - Conversion | -6.609.027 | 0 | -100,00 | ||||
2020-12-08 |
|
4 | SBTX |
Silverback Therapeutics, Inc.
Common Stock |
P - Purchase | 47.619 | 47.619 | 21,00 | 999.999 | 999.999 | ||
2020-12-08 |
|
4 | SBTX |
Silverback Therapeutics, Inc.
Common Stock |
C - Conversion | 14.677 | 105.012 | 16,25 | ||||
2020-12-08 |
|
4 | SBTX |
Silverback Therapeutics, Inc.
Common Stock |
C - Conversion | 90.335 | 90.335 | |||||
2020-12-08 |
|
4 | SBTX |
Silverback Therapeutics, Inc.
Common Stock |
C - Conversion | 289.198 | 2.069.167 | 16,25 | ||||
2020-12-08 |
|
4 | SBTX |
Silverback Therapeutics, Inc.
Common Stock |
C - Conversion | 1.779.969 | 1.779.969 | |||||
2020-11-19 |
|
4 | NARI |
Inari Medical, Inc.
Common Stock |
S - Sale | -20.000 | 40.883 | -32,85 | 66,38 | -1.327.600 | 2.713.814 | |
2020-11-19 |
|
4 | NARI |
Inari Medical, Inc.
Common Stock |
J - Other | 34.576 | 34.576 | |||||
2020-11-19 |
|
4 | NARI |
Inari Medical, Inc.
Common Stock |
J - Other | 34.576 | 34.576 | |||||
2020-11-19 |
|
4 | NARI |
Inari Medical, Inc.
Common Stock |
J - Other | 11.794 | 11.794 | |||||
2020-11-19 |
|
4 | NARI |
Inari Medical, Inc.
Common Stock |
J - Other | 67.730 | 67.730 | |||||
2020-11-19 |
|
4 | NARI |
Inari Medical, Inc.
Common Stock |
J - Other | 56.173 | 56.173 | |||||
2020-11-19 |
|
4 | NARI |
Inari Medical, Inc.
Common Stock |
J - Other | 60.883 | 60.883 | |||||
2020-11-19 |
|
4 | NARI |
Inari Medical, Inc.
Common Stock |
J - Other | 37.268 | 37.268 | |||||
2020-11-19 |
|
4 | NARI |
Inari Medical, Inc.
Common Stock |
J - Other | -587.851 | 0 | -100,00 | ||||
2020-11-19 |
|
4 | NARI |
Inari Medical, Inc.
Common Stock |
J - Other | 587.851 | 587.851 | |||||
2020-11-19 |
|
4 | NARI |
Inari Medical, Inc.
Common Stock |
J - Other | -71.840 | 167.627 | -30,00 | ||||
2020-11-19 |
|
4 | NARI |
Inari Medical, Inc.
Common Stock |
J - Other | -2.245.605 | 5.239.744 | -30,00 | ||||
2020-10-13 |
|
4 | INSP |
Inspire Medical Systems, Inc.
Common Stock |
A - Award | 105 | 18.935 | 0,56 | 130,00 | 13.650 | 2.461.550 | |
2020-09-16 |
|
4 | INSP |
Inspire Medical Systems, Inc.
Common Stock |
S - Sale | -2.026 | 18.830 | -9,71 | 130,01 | -263.400 | 2.448.088 | |
2020-09-16 |
|
4 | INSP |
Inspire Medical Systems, Inc.
Common Stock |
S - Sale | -6.154 | 20.856 | -22,78 | 129,45 | -796.635 | 2.699.809 | |
2020-09-16 |
|
4 | INSP |
Inspire Medical Systems, Inc.
Common Stock |
S - Sale | -3.820 | 27.010 | -12,39 | 128,58 | -491.176 | 3.472.946 | |
2020-07-14 |
|
4 | INSP |
Inspire Medical Systems, Inc.
Common Stock |
A - Award | 149 | 30.830 | 0,49 | ||||
2020-06-17 |
|
4 | INSP |
Inspire Medical Systems, Inc.
Common Stock |
S - Sale | -24.563 | 30.681 | -44,46 | 85,28 | -2.094.733 | 2.616.476 | |
2020-06-17 |
|
4 | INSP |
Inspire Medical Systems, Inc.
Common Stock |
S - Sale | -33.552 | 55.244 | -37,79 | 84,75 | -2.843.532 | 4.681.929 | |
2020-06-17 |
|
4 | INSP |
Inspire Medical Systems, Inc.
Common Stock |
S - Sale | -26.353 | 88.796 | -22,89 | 83,53 | -2.201.266 | 7.417.130 | |
2020-06-17 |
|
4 | INSP |
Inspire Medical Systems, Inc.
Common Stock |
S - Sale | -4.383 | 115.149 | -3,67 | 82,70 | -362.474 | 9.522.822 | |
2020-06-17 |
|
4 | INSP |
Inspire Medical Systems, Inc.
Common Stock |
S - Sale | -5.198 | 119.532 | -4,17 | 81,85 | -425.456 | 9.783.694 | |
2020-06-17 |
|
4 | INSP |
Inspire Medical Systems, Inc.
Common Stock |
S - Sale | -5.951 | 124.730 | -4,55 | 80,12 | -476.794 | 9.993.368 | |
2020-05-27 |
|
4 | NARI |
Inari Medical, Inc.
Series C Preferred Stock |
C - Conversion | -72.887 | 0 | -100,00 | ||||
2020-05-27 |
|
4 | NARI |
Inari Medical, Inc.
Series C Preferred Stock |
C - Conversion | -2.278.331 | 0 | -100,00 | ||||
2020-05-27 |
|
4 | NARI |
Inari Medical, Inc.
Series B Preferred Stock |
C - Conversion | -92.771 | 0 | -100,00 | ||||
2020-05-27 |
|
4 | NARI |
Inari Medical, Inc.
Series B Preferred Stock |
C - Conversion | -2.899.876 | 0 | -100,00 | ||||
2020-05-27 |
|
4 | NARI |
Inari Medical, Inc.
Series A Preferred Stock |
C - Conversion | -73.809 | 0 | -100,00 | ||||
2020-05-27 |
|
4 | NARI |
Inari Medical, Inc.
Series A Preferred Stock |
C - Conversion | -2.307.142 | 0 | -100,00 | ||||
2020-05-27 |
|
4 | NARI |
Inari Medical, Inc.
Common Stock |
P - Purchase | 97.962 | 97.962 | 19,00 | 1.861.278 | 1.861.278 | ||
2020-05-27 |
|
4 | NARI |
Inari Medical, Inc.
Common Stock |
C - Conversion | 72.887 | 239.467 | 43,75 | ||||
2020-05-27 |
|
4 | NARI |
Inari Medical, Inc.
Common Stock |
C - Conversion | 92.771 | 166.580 | 125,69 | ||||
2020-05-27 |
|
4 | NARI |
Inari Medical, Inc.
Common Stock |
C - Conversion | 73.809 | 73.809 | |||||
2020-05-27 |
|
4 | NARI |
Inari Medical, Inc.
Common Stock |
C - Conversion | 2.278.331 | 7.485.349 | 43,76 | ||||
2020-05-27 |
|
4 | NARI |
Inari Medical, Inc.
Common Stock |
C - Conversion | 2.899.876 | 5.207.018 | 125,69 | ||||
2020-05-27 |
|
4 | NARI |
Inari Medical, Inc.
Common Stock |
C - Conversion | 2.307.142 | 2.307.142 | |||||
2020-05-04 |
|
4 | INSP |
Inspire Medical Systems, Inc.
Stock Option (right to buy) |
A - Award | 3.501 | 3.501 | |||||
2020-04-14 |
|
4 | INSP |
Inspire Medical Systems, Inc.
Common Stock |
A - Award | 212 | 130.681 | 0,16 | ||||
2020-03-03 |
|
4 | INSP |
Inspire Medical Systems, Inc.
Common Stock |
S - Sale | -300 | 130.469 | -0,23 | 88,22 | -26.466 | 11.509.975 | |
2020-03-03 |
|
4 | INSP |
Inspire Medical Systems, Inc.
Common Stock |
S - Sale | -300 | 130.769 | -0,23 | 87,40 | -26.220 | 11.429.211 | |
2020-03-03 |
|
4 | INSP |
Inspire Medical Systems, Inc.
Common Stock |
S - Sale | -1.100 | 131.069 | -0,83 | 85,45 | -93.995 | 11.199.846 | |
2020-03-03 |
|
4 | INSP |
Inspire Medical Systems, Inc.
Common Stock |
S - Sale | -4.456 | 132.169 | -3,26 | 84,32 | -375.730 | 11.144.490 | |
2020-03-03 |
|
4 | INSP |
Inspire Medical Systems, Inc.
Common Stock |
S - Sale | -41.332 | 136.625 | -23,23 | 83,23 | -3.440.062 | 11.371.299 | |
2020-03-03 |
|
4 | INSP |
Inspire Medical Systems, Inc.
Common Stock |
S - Sale | -22.512 | 177.957 | -11,23 | 82,51 | -1.857.465 | 14.683.232 | |
2020-01-14 |
|
4 | INSP |
Inspire Medical Systems, Inc.
Common Stock |
A - Award | 170 | 200.469 | 0,08 | 80,63 | 13.707 | 16.163.815 | |
2019-10-15 |
|
4 | INSP |
Inspire Medical Systems, Inc.
Common Stock |
A - Award | 250 | 200.299 | 0,12 | 54,84 | 13.710 | 10.984.397 | |
2019-07-17 |
|
4 | INSP |
Inspire Medical Systems, Inc.
Common Stock |
A - Award | 199 | 200.049 | 0,10 | 68,88 | 13.707 | 13.779.375 | |
2019-05-06 |
|
4 | INSP |
Inspire Medical Systems, Inc.
Stock Option (right to buy) |
A - Award | 4.569 | 4.569 | |||||
2019-04-12 |
|
4 | INSP |
Inspire Medical Systems, Inc.
Common Stock |
A - Award | 247 | 199.850 | 0,12 | 55,63 | 13.741 | 11.117.656 | |
2019-03-07 |
|
4 | INSP |
Inspire Medical Systems, Inc.
Common Stock |
S - Sale | -25.000 | 199.603 | -11,13 | 54,78 | -1.369.395 | 10.933.414 | |
2019-03-07 |
|
4 | INSP |
Inspire Medical Systems, Inc.
Common Stock |
J - Other | -1.084.127 | 0 | -100,00 | ||||
2019-03-07 |
|
4 | INSP |
Inspire Medical Systems, Inc.
Common Stock |
J - Other | 22.923 | 224.603 | 11,37 | ||||
2019-01-14 |
|
4 | INSP |
Inspire Medical Systems, Inc.
Common Stock |
A - Award | 295 | 201.680 | 0,15 | 46,58 | 13.741 | 9.394.254 | |
2018-11-13 |
|
4 | IMI |
INTERMOLECULAR INC
Common Stock, $0.001 per share |
S - Sale | -2.400 | 97.593 | -2,40 | 0,95 | -2.280 | 92.713 | |
2018-11-13 |
|
4 | IMI |
INTERMOLECULAR INC
Common Stock, $0.001 per share |
S - Sale | -2.100 | 99.993 | -2,06 | 0,96 | -2.007 | 95.553 | |
2018-11-13 |
|
4 | IMI |
INTERMOLECULAR INC
Common Stock, $0.001 per share |
J - Other | 82.370 | 82.370 | |||||
2018-11-13 |
|
4 | IMI |
INTERMOLECULAR INC
Common Stock, $0.001 per share |
J - Other | 60.336 | 60.336 | |||||
2018-11-13 |
|
4 | IMI |
INTERMOLECULAR INC
Common Stock, $0.001 per share |
J - Other | 85.851 | 85.851 | |||||
2018-11-13 |
|
4 | IMI |
INTERMOLECULAR INC
Common Stock, $0.001 per share |
J - Other | 60.408 | 60.408 | |||||
2018-11-13 |
|
4 | IMI |
INTERMOLECULAR INC
Common Stock, $0.001 per share |
J - Other | 69.609 | 69.609 | |||||
2018-11-13 |
|
4 | IMI |
INTERMOLECULAR INC
Common Stock, $0.001 per share |
J - Other | 102.093 | 102.093 | |||||
2018-11-13 |
|
4 | IMI |
INTERMOLECULAR INC
Common Stock, $0.001 per share |
J - Other | -856.155 | 0 | -100,00 | ||||
2018-11-13 |
|
4 | IMI |
INTERMOLECULAR INC
Common Stock, $0.001 per share |
J - Other | 856.155 | 856.155 | |||||
2018-11-13 |
|
4 | IMI |
INTERMOLECULAR INC
Common Stock, $0.001 per share |
J - Other | -4.280.779 | 0 | -100,00 | ||||
2018-11-13 |
|
4 | INSP |
Inspire Medical Systems, Inc.
Common Stock |
J - Other | -1.084.127 | 1.084.127 | -50,00 | ||||
2018-11-13 |
|
4 | INSP |
Inspire Medical Systems, Inc.
Common Stock |
J - Other | 13.340 | 201.385 | 7,09 | ||||
2018-10-12 |
|
4 | INSP |
Inspire Medical Systems, Inc.
Common Stock |
A - Award | 338 | 188.045 | 0,18 | 40,60 | 13.723 | 7.634.627 | |
2018-07-16 |
|
4 | INSP |
Inspire Medical Systems, Inc.
Common Stock |
A - Award | 207 | 187.707 | 0,11 | 43,00 | 8.901 | 8.071.401 | |
2018-05-09 |
|
4 | INSP |
Inspire Medical Systems, Inc.
Series F Convertible Preferred Stock |
C - Conversion | -3.795.620 | 0 | -100,00 | ||||
2018-05-09 |
|
4 | INSP |
Inspire Medical Systems, Inc.
Series E Convertible Preferred Stock |
C - Conversion | -948.855 | 0 | -100,00 | ||||
2018-05-09 |
|
4 | INSP |
Inspire Medical Systems, Inc.
Series D Convertible Preferred Stock |
C - Conversion | -1.397.478 | 0 | -100,00 | ||||
2018-05-09 |
|
4 | INSP |
Inspire Medical Systems, Inc.
Series C Convertible Preferred Stock |
C - Conversion | -3.142.670 | 0 | -100,00 | ||||
2018-05-09 |
|
4 | INSP |
Inspire Medical Systems, Inc.
Series B Convertible Preferred Stock |
C - Conversion | -2.102.315 | 0 | -100,00 | ||||
2018-05-09 |
|
4 | INSP |
Inspire Medical Systems, Inc.
Series A Convertible Preferred Stock |
C - Conversion | -2.400.000 | 0 | -100,00 | ||||
2018-05-09 |
|
4 | INSP |
Inspire Medical Systems, Inc.
Common Stock |
P - Purchase | 187.500 | 187.500 | 16,00 | 3.000.000 | 3.000.000 | ||
2018-05-09 |
|
4 | INSP |
Inspire Medical Systems, Inc.
Common Stock |
C - Conversion | 570.769 | 2.168.254 | 35,73 | ||||
2018-05-09 |
|
4 | INSP |
Inspire Medical Systems, Inc.
Common Stock |
C - Conversion | 163.962 | 1.597.485 | 11,44 | ||||
2018-05-09 |
|
4 | INSP |
Inspire Medical Systems, Inc.
Common Stock |
C - Conversion | 210.147 | 1.433.523 | 17,18 | ||||
2018-05-09 |
|
4 | INSP |
Inspire Medical Systems, Inc.
Common Stock |
C - Conversion | 472.581 | 1.223.376 | 62,94 | ||||
2018-05-09 |
|
4 | INSP |
Inspire Medical Systems, Inc.
Common Stock |
C - Conversion | 389.893 | 750.795 | 108,03 | ||||
2018-05-09 |
|
4 | INSP |
Inspire Medical Systems, Inc.
Common Stock |
C - Conversion | 360.902 | 360.902 | |||||
2018-05-09 |
|
4 | INSP |
Inspire Medical Systems, Inc.
Employee Stock Option (right to buy) |
A - Award | 17.296 | 17.296 | |||||
2017-06-08 |
|
4/A | BOX |
BOX INC
Class B Common Stock |
C - Conversion | -8.000.000 | 3.713.775 | -68,30 | ||||
2017-06-08 |
|
4/A | BOX |
BOX INC
Class A Common Stock |
J - Other | -8.000.000 | 0 | -100,00 | ||||
2017-06-08 |
|
4/A | BOX |
BOX INC
Class A Common Stock |
C - Conversion | 8.000.000 | 8.000.000 | |||||
2017-06-05 |
|
4 | BOX |
BOX INC
Class B Common Stock |
C - Conversion | -8.000.000 | 3.713.775 | -68,30 | ||||
2017-06-05 |
|
4 | BOX |
BOX INC
Class A Common Stock |
J - Other | -8.000.000 | 0 | -100,00 | ||||
2017-06-05 |
|
4 | BOX |
BOX INC
Class A Common Stock |
C - Conversion | 8.000.000 | 8.000.000 | |||||
2017-06-05 |
|
4 | XENT |
Intersect ENT, Inc.
Stock Options (Right to buy) |
A - Award | 6.035 | 6.035 | |||||
2017-06-05 |
|
4 | XENT |
Intersect ENT, Inc.
Common Stock |
A - Award | 2.546 | 2.546 | |||||
2017-05-10 |
|
4 | XENT |
Intersect ENT, Inc.
Common Stock |
J - Other | -1.995.433 | 0 | -100,00 | ||||
2017-01-20 |
|
4 | XENT |
Intersect ENT, Inc.
Stock Options (Right to buy) |
A - Award | 7.570 | 7.570 | |||||
2016-06-06 |
|
4 | XENT |
Intersect ENT, Inc.
Stock Option (right to buy) |
A - Award | 12.500 | 12.500 | |||||
2015-06-05 |
|
4 | XENT |
Intersect ENT, Inc.
Stock Options (Right to buy) |
A - Award | 12.500 | 12.500 | |||||
2015-05-11 |
|
4 | XENT |
Intersect ENT, Inc.
Common Stock |
J - Other | -990.000 | 1.995.433 | -33,16 | ||||
2015-03-06 |
|
4 | XENT |
Intersect ENT, Inc.
Common Stock |
J - Other | -990.000 | 2.985.433 | -24,90 | ||||
2015-01-30 |
|
4 | BOX |
BOX INC
Class B Common Stock |
J - Other | 11.713.775 | 11.713.775 | |||||
2015-01-30 |
|
4 | BOX |
BOX INC
Series D Preferred Stock |
C - Conversion | -943.672 | 0 | -100,00 | ||||
2015-01-30 |
|
4 | BOX |
BOX INC
Series C Preferred Stock |
C - Conversion | -2.486.922 | 0 | -100,00 | ||||
2015-01-30 |
|
4 | BOX |
BOX INC
Series B Preferred Stock |
C - Conversion | -8.283.181 | 0 | -100,00 | ||||
2015-01-30 |
|
4 | BOX |
BOX INC
Existing Class A Common Stock |
J - Other | -11.713.775 | 0 | -100,00 | ||||
2015-01-30 |
|
4 | BOX |
BOX INC
Existing Class A Common Stock |
C - Conversion | 11.713.775 | 11.713.775 | |||||
2014-09-26 |
|
4 | XENT |
Intersect ENT, Inc.
Stock Option (right to buy) |
A - Award | 12.500 | 12.500 | |||||
2014-09-10 |
|
4 | CSLT |
CASTLIGHT HEALTH, INC.
Class B Common Stock |
J - Other | -37.443 | 0 | -100,00 | ||||
2014-09-10 |
|
4 | CSLT |
CASTLIGHT HEALTH, INC.
Class B Common Stock |
J - Other | -1.170.392 | 0 | -100,00 | ||||
2014-09-10 |
|
4 | CSLT |
CASTLIGHT HEALTH, INC.
Class B Common Stock |
C - Conversion | 37.443 | 37.443 | |||||
2014-09-10 |
|
4 | CSLT |
CASTLIGHT HEALTH, INC.
Class B Common Stock |
C - Conversion | 1.170.392 | 1.170.392 | |||||
2014-09-10 |
|
4 | CSLT |
CASTLIGHT HEALTH, INC.
Class A Common Stock |
C - Conversion | -37.443 | 37.443 | -50,00 | ||||
2014-09-10 |
|
4 | CSLT |
CASTLIGHT HEALTH, INC.
Class A Common Stock |
C - Conversion | -1.170.392 | 1.170.392 | -50,00 | ||||
2014-08-12 |
|
4 | OMED |
OncoMed Pharmaceuticals Inc
Common Stock |
J - Other | 27.572 | 56.528 | 95,22 | ||||
2014-08-12 |
|
4 | OMED |
OncoMed Pharmaceuticals Inc
Common Stock |
J - Other | 8.863 | 18.170 | 95,23 | ||||
2014-08-12 |
|
4 | OMED |
OncoMed Pharmaceuticals Inc
Common Stock |
J - Other | 27.573 | 27.573 | |||||
2014-08-12 |
|
4 | OMED |
OncoMed Pharmaceuticals Inc
Common Stock |
J - Other | 33.089 | 50.471 | 190,36 | ||||
2014-08-12 |
|
4 | OMED |
OncoMed Pharmaceuticals Inc
Common Stock |
J - Other | 27.573 | 27.573 | |||||
2014-08-12 |
|
4 | OMED |
OncoMed Pharmaceuticals Inc
Common Stock |
J - Other | -285.734 | 0 | -100,00 | ||||
2014-08-12 |
|
4 | OMED |
OncoMed Pharmaceuticals Inc
Common Stock |
J - Other | 285.734 | 285.734 | |||||
2014-08-12 |
|
4 | OMED |
OncoMed Pharmaceuticals Inc
Common Stock |
J - Other | -9.046 | 19.215 | -32,01 | ||||
2014-08-12 |
|
4 | OMED |
OncoMed Pharmaceuticals Inc
Common Stock |
J - Other | -937.205 | 1.990.783 | -32,01 | ||||
2014-07-30 |
|
4 | XENT |
Intersect ENT, Inc.
Series D Convertible Preferred Stock |
C - Conversion | -746.054 | 0 | -100,00 | ||||
2014-07-30 |
|
4 | XENT |
Intersect ENT, Inc.
Series C Convertible Preferred Stock |
C - Conversion | -1.292.216 | 0 | -100,00 | ||||
2014-07-30 |
|
4 | XENT |
Intersect ENT, Inc.
Series B Convertible Preferred Stock |
C - Conversion | -817.034 | 0 | -100,00 | ||||
2014-07-30 |
|
4 | XENT |
Intersect ENT, Inc.
Series A Convertible Preferred Stock |
C - Conversion | -1.120.129 | 0 | -100,00 | ||||
2014-07-30 |
|
4 | XENT |
Intersect ENT, Inc.
Common Stock |
C - Conversion | 746.054 | 3.975.433 | 23,10 | ||||
2014-07-30 |
|
4 | XENT |
Intersect ENT, Inc.
Common Stock |
C - Conversion | 1.292.216 | 3.229.379 | 66,71 | ||||
2014-07-30 |
|
4 | XENT |
Intersect ENT, Inc.
Common Stock |
C - Conversion | 817.034 | 1.937.163 | 72,94 | ||||
2014-07-30 |
|
4 | XENT |
Intersect ENT, Inc.
Common Stock |
C - Conversion | 1.120.129 | 1.120.129 | |||||
2014-05-13 |
|
4 | OMED |
OncoMed Pharmaceuticals Inc
Common Stock |
S - Sale | -28.956 | 0 | -100,00 | 21,99 | -636.742 | ||
2014-05-13 |
|
4 | OMED |
OncoMed Pharmaceuticals Inc
Common Stock |
S - Sale | -17.371 | 17.382 | -49,98 | 21,98 | -381.815 | 382.056 | |
2014-05-13 |
|
4 | OMED |
OncoMed Pharmaceuticals Inc
Common Stock |
J - Other | 28.956 | 28.956 | |||||
2014-05-13 |
|
4 | OMED |
OncoMed Pharmaceuticals Inc
Common Stock |
J - Other | 28.956 | 28.956 | |||||
2014-05-13 |
|
4 | OMED |
OncoMed Pharmaceuticals Inc
Common Stock |
J - Other | 9.307 | 9.307 | |||||
2014-05-13 |
|
4 | OMED |
OncoMed Pharmaceuticals Inc
Common Stock |
J - Other | 34.743 | 34.743 | |||||
2014-05-13 |
|
4 | OMED |
OncoMed Pharmaceuticals Inc
Common Stock |
J - Other | 28.966 | 28.966 | |||||
2014-05-13 |
|
4 | OMED |
OncoMed Pharmaceuticals Inc
Common Stock |
J - Other | -300.063 | 0 | -100,00 | ||||
2014-05-13 |
|
4 | OMED |
OncoMed Pharmaceuticals Inc
Common Stock |
J - Other | 300.063 | 300.063 | |||||
2014-05-13 |
|
4 | OMED |
OncoMed Pharmaceuticals Inc
Common Stock |
J - Other | -9.421 | 28.261 | -25,00 | ||||
2014-05-13 |
|
4 | OMED |
OncoMed Pharmaceuticals Inc
Common Stock |
J - Other | -975.996 | 2.927.988 | -25,00 | ||||
2014-03-20 |
|
4 | CSLT |
CASTLIGHT HEALTH, INC.
Series D Preferred Stock |
C - Conversion | -15.668 | 0 | -100,00 | ||||
2014-03-20 |
|
4 | CSLT |
CASTLIGHT HEALTH, INC.
Series C Preferred Stock |
C - Conversion | -52.784 | 0 | -100,00 | ||||
2014-03-20 |
|
4 | CSLT |
CASTLIGHT HEALTH, INC.
Series A1 Preferred Stock |
C - Conversion | -1.639 | 0 | -100,00 | ||||
2014-03-20 |
|
4 | CSLT |
CASTLIGHT HEALTH, INC.
Series A Preferred Stock |
C - Conversion | -4.170 | 0 | -100,00 | ||||
2014-03-20 |
|
4 | CSLT |
CASTLIGHT HEALTH, INC.
Series D Preferred Stock |
C - Conversion | -489.752 | 0 | -100,00 | ||||
2014-03-20 |
|
4 | CSLT |
CASTLIGHT HEALTH, INC.
Series C Preferred Stock |
C - Conversion | -1.649.919 | 0 | -100,00 | ||||
2014-03-20 |
|
4 | CSLT |
CASTLIGHT HEALTH, INC.
Series A1 Preferred Stock |
C - Conversion | -51.223 | 0 | -100,00 | ||||
2014-03-20 |
|
4 | CSLT |
CASTLIGHT HEALTH, INC.
Series A Preferred Stock |
C - Conversion | -130.339 | 0 | -100,00 | ||||
2014-03-20 |
|
4 | CSLT |
CASTLIGHT HEALTH, INC.
Class A Common Stock |
C - Conversion | 74.261 | 74.886 | 11.881,76 | ||||
2014-03-20 |
|
4 | CSLT |
CASTLIGHT HEALTH, INC.
Class A Common Stock |
C - Conversion | 2.321.233 | 2.340.784 | 11.872,71 | ||||
2014-03-13 | 3 | CSLT |
CASTLIGHT HEALTH, INC.
Class A Common Stock |
39.727 | ||||||||
2014-03-13 | 3 | CSLT |
CASTLIGHT HEALTH, INC.
Class A Common Stock |
20.801 | ||||||||
2014-03-13 | 3 | CSLT |
CASTLIGHT HEALTH, INC.
Class A Common Stock |
39.727 | ||||||||
2014-03-13 | 3 | CSLT |
CASTLIGHT HEALTH, INC.
Class A Common Stock |
20.801 | ||||||||
2014-03-13 | 3 | CSLT |
CASTLIGHT HEALTH, INC.
Class A Common Stock |
39.727 | ||||||||
2014-03-13 | 3 | CSLT |
CASTLIGHT HEALTH, INC.
Class A Common Stock |
20.801 | ||||||||
2014-03-13 | 3 | CSLT |
CASTLIGHT HEALTH, INC.
Class A Common Stock |
39.727 | ||||||||
2014-03-13 | 3 | CSLT |
CASTLIGHT HEALTH, INC.
Class A Common Stock |
20.801 | ||||||||
2014-03-13 | 3 | CSLT |
CASTLIGHT HEALTH, INC.
Class A Common Stock |
39.727 | ||||||||
2014-03-13 | 3 | CSLT |
CASTLIGHT HEALTH, INC.
Class A Common Stock |
20.801 | ||||||||
2014-03-13 | 3 | CSLT |
CASTLIGHT HEALTH, INC.
Class A Common Stock |
39.727 | ||||||||
2014-03-13 | 3 | CSLT |
CASTLIGHT HEALTH, INC.
Class A Common Stock |
20.801 | ||||||||
2014-03-13 | 3 | CSLT |
CASTLIGHT HEALTH, INC.
Class A Common Stock |
39.727 | ||||||||
2014-03-13 | 3 | CSLT |
CASTLIGHT HEALTH, INC.
Class A Common Stock |
20.801 | ||||||||
2014-03-13 | 3 | CSLT |
CASTLIGHT HEALTH, INC.
Class A Common Stock |
39.727 | ||||||||
2014-03-13 | 3 | CSLT |
CASTLIGHT HEALTH, INC.
Class A Common Stock |
20.801 | ||||||||
2014-03-13 | 3 | CSLT |
CASTLIGHT HEALTH, INC.
Class A Common Stock |
39.727 | ||||||||
2014-03-13 | 3 | CSLT |
CASTLIGHT HEALTH, INC.
Class A Common Stock |
20.801 | ||||||||
2013-07-23 |
|
4 | OMED |
OncoMed Pharmaceuticals Inc
Series B-1 Preferred Stock |
C - Conversion | -14.527 | 0 | -100,00 | ||||
2013-07-23 |
|
4 | OMED |
OncoMed Pharmaceuticals Inc
Series B-1 Preferred Stock |
C - Conversion | -7.051 | 0 | -100,00 | ||||
2013-07-23 |
|
4 | OMED |
OncoMed Pharmaceuticals Inc
Series B-1 Preferred Stock |
C - Conversion | -13.910 | 0 | -100,00 | ||||
2013-07-23 |
|
4 | OMED |
OncoMed Pharmaceuticals Inc
Series B-1 Preferred Stock |
C - Conversion | -1.505.032 | 0 | -100,00 | ||||
2013-07-23 |
|
4 | OMED |
OncoMed Pharmaceuticals Inc
Series B Preferred Stock |
C - Conversion | -11.731 | 0 | -100,00 | ||||
2013-07-23 |
|
4 | OMED |
OncoMed Pharmaceuticals Inc
Series B Preferred Stock |
C - Conversion | -5.694 | 0 | -100,00 | ||||
2013-07-23 |
|
4 | OMED |
OncoMed Pharmaceuticals Inc
Series B Preferred Stock |
C - Conversion | -11.233 | 0 | -100,00 | ||||
2013-07-23 |
|
4 | OMED |
OncoMed Pharmaceuticals Inc
Series B Preferred Stock |
C - Conversion | -1.215.407 | 0 | -100,00 | ||||
2013-07-23 |
|
4 | OMED |
OncoMed Pharmaceuticals Inc
Series A Preferred Stock |
C - Conversion | -9.926 | 0 | -100,00 | ||||
2013-07-23 |
|
4 | OMED |
OncoMed Pharmaceuticals Inc
Series A Preferred Stock |
C - Conversion | -4.817 | 0 | -100,00 | ||||
2013-07-23 |
|
4 | OMED |
OncoMed Pharmaceuticals Inc
Series A Preferred Stock |
C - Conversion | -9.505 | 0 | -100,00 | ||||
2013-07-23 |
|
4 | OMED |
OncoMed Pharmaceuticals Inc
Series A Preferred Stock |
C - Conversion | -1.028.381 | 0 | -100,00 | ||||
2013-07-23 |
|
4 | OMED |
OncoMed Pharmaceuticals Inc
Common Stock |
P - Purchase | 1.498 | 37.682 | 4,14 | 17,00 | 25.466 | 640.594 | |
2013-07-23 |
|
4 | OMED |
OncoMed Pharmaceuticals Inc
Common Stock |
C - Conversion | 14.527 | 36.184 | 67,08 | ||||
2013-07-23 |
|
4 | OMED |
OncoMed Pharmaceuticals Inc
Common Stock |
C - Conversion | 11.731 | 21.657 | 118,18 | ||||
2013-07-23 |
|
4 | OMED |
OncoMed Pharmaceuticals Inc
Common Stock |
C - Conversion | 9.926 | 9.926 | |||||
2013-07-23 |
|
4 | OMED |
OncoMed Pharmaceuticals Inc
Common Stock |
P - Purchase | 727 | 18.289 | 4,14 | 17,00 | 12.359 | 310.913 | |
2013-07-23 |
|
4 | OMED |
OncoMed Pharmaceuticals Inc
Common Stock |
C - Conversion | 7.051 | 17.562 | 67,08 | ||||
2013-07-23 |
|
4 | OMED |
OncoMed Pharmaceuticals Inc
Common Stock |
C - Conversion | 5.694 | 10.511 | 118,21 | ||||
2013-07-23 |
|
4 | OMED |
OncoMed Pharmaceuticals Inc
Common Stock |
C - Conversion | 4.817 | 4.817 | |||||
2013-07-23 |
|
4 | OMED |
OncoMed Pharmaceuticals Inc
Common Stock |
P - Purchase | 1.434 | 36.082 | 4,14 | 17,00 | 24.378 | 613.394 | |
2013-07-23 |
|
4 | OMED |
OncoMed Pharmaceuticals Inc
Common Stock |
C - Conversion | 13.910 | 34.648 | 67,07 | ||||
2013-07-23 |
|
4 | OMED |
OncoMed Pharmaceuticals Inc
Common Stock |
C - Conversion | 11.233 | 20.738 | 118,18 | ||||
2013-07-23 |
|
4 | OMED |
OncoMed Pharmaceuticals Inc
Common Stock |
C - Conversion | 9.505 | 9.505 | |||||
2013-07-23 |
|
4 | OMED |
OncoMed Pharmaceuticals Inc
Common Stock |
P - Purchase | 155.164 | 3.903.984 | 4,14 | 17,00 | 2.637.788 | 66.367.728 | |
2013-07-23 |
|
4 | OMED |
OncoMed Pharmaceuticals Inc
Common Stock |
C - Conversion | 1.505.032 | 3.748.820 | 67,08 | ||||
2013-07-23 |
|
4 | OMED |
OncoMed Pharmaceuticals Inc
Common Stock |
C - Conversion | 1.215.407 | 2.243.788 | 118,19 | ||||
2013-07-23 |
|
4 | OMED |
OncoMed Pharmaceuticals Inc
Common Stock |
C - Conversion | 1.028.381 | 1.028.381 | |||||
2012-09-25 |
|
4 | GWRE |
Guidewire Software, Inc.
Common Stock |
J - Other | -14.737 | 36.638 | -28,69 | ||||
2012-09-25 |
|
4 | GWRE |
Guidewire Software, Inc.
Common Stock |
J - Other | -2.000.000 | 4.972.862 | -28,68 | ||||
2012-09-18 |
|
4 | GWRE |
Guidewire Software, Inc.
Common Stock |
S - Sale | -1.669 | 35.047 | -4,55 | 31,13 | -51.955 | 1.091.003 | |
2012-09-18 |
|
4 | GWRE |
Guidewire Software, Inc.
Common Stock |
S - Sale | -3.111 | 65.325 | -4,55 | 31,13 | -96.844 | 2.033.548 | |
2012-09-18 |
|
4 | GWRE |
Guidewire Software, Inc.
Common Stock |
S - Sale | -7.127 | 36.716 | -16,26 | 31,30 | -223.091 | 1.149.295 | |
2012-09-18 |
|
4 | GWRE |
Guidewire Software, Inc.
Common Stock |
S - Sale | -13.284 | 68.436 | -16,26 | 31,30 | -415.820 | 2.142.204 | |
2012-09-12 |
|
4 | GWRE |
Guidewire Software, Inc.
Common Stock |
J - Other | -12.895 | 51.375 | -20,06 | ||||
2012-09-12 |
|
4 | GWRE |
Guidewire Software, Inc.
Common Stock |
J - Other | -1.750.000 | 6.972.862 | -20,06 | ||||
2012-08-22 |
|
4 | MXL |
MAXLINEAR INC
Class B Common Stock (convertible into Class A Common Stock) |
S - Sale | -2.289 | 10.969 | -17,27 | 5,59 | -12.796 | 61.317 | |
2012-08-22 |
|
4 | MXL |
MAXLINEAR INC
Class B Common Stock (convertible into Class A Common Stock) |
S - Sale | -4.515 | 21.639 | -17,26 | 5,59 | -25.239 | 120.962 | |
2012-08-22 |
|
4 | MXL |
MAXLINEAR INC
Class B Common Stock (convertible into Class A Common Stock) |
S - Sale | -4.715 | 22.599 | -17,26 | 5,59 | -26.357 | 126.328 | |
2012-08-22 |
|
4 | MXL |
MAXLINEAR INC
Class B Common Stock (convertible into Class A Common Stock) |
S - Sale | -488.481 | 2.341.364 | -17,26 | 5,59 | -2.730.609 | 13.088.225 | |
2012-06-15 |
|
4 | IMI |
INTERMOLECULAR INC
Common Stock, $0.001 per share |
S - Sale | -1.209 | 4.280.779 | -0,03 | 6,70 | -8.100 | 28.681.219 | |
2012-06-14 |
|
4 | ATRC |
AtriCure, Inc.
Common Stock |
J - Other | -2.579 | 11.873 | -17,85 | ||||
2012-06-14 |
|
4 | ATRC |
AtriCure, Inc.
Common Stock |
J - Other | -350.000 | 1.502.444 | -18,89 | ||||
2012-06-13 |
|
4 | IMI |
INTERMOLECULAR INC
Common Stock, $0.001 per share |
S - Sale | -15.263 | 4.281.988 | -0,36 | 6,80 | -103.773 | 29.113.236 | |
2012-06-13 |
|
4 | IMI |
INTERMOLECULAR INC
Common Stock, $0.001 per share |
S - Sale | -53.368 | 4.297.251 | -1,23 | 6,78 | -361.995 | 29.148.254 | |
2012-06-13 |
|
4 | IMI |
INTERMOLECULAR INC
Common Stock, $0.001 per share |
S - Sale | -150.000 | 4.350.619 | -3,33 | 6,75 | -1.012.500 | 29.366.678 | |
2012-06-07 |
|
4 | ATRC |
AtriCure, Inc.
Common Stock |
S - Sale | -1.759 | 9.858 | -15,14 | 9,44 | -16.612 | 93.099 | |
2012-06-07 |
|
4 | ATRC |
AtriCure, Inc.
Common Stock |
S - Sale | -3.279 | 18.374 | -15,14 | 9,44 | -30.967 | 173.524 | |
2012-06-07 |
|
4 | ATRC |
AtriCure, Inc.
Common Stock |
J - Other | -2.579 | 14.452 | -15,14 | ||||
2012-06-07 |
|
4 | ATRC |
AtriCure, Inc.
Common Stock |
J - Other | -350.000 | 1.852.444 | -15,89 | ||||
2012-05-31 |
|
4 | IMI |
INTERMOLECULAR INC
Common Stock, $0.001 per share |
S - Sale | -338.500 | 4.500.619 | -7,00 | 6,55 | -2.217.344 | 29.481.305 | |
2012-05-31 |
|
4 | MXL |
MAXLINEAR INC
Class A Common Stock ($0.0001 par value) |
S - Sale | -1.640 | 0 | -100,00 | 4,20 | -6.891 | ||
2012-05-31 |
|
4 | MXL |
MAXLINEAR INC
Class A Common Stock ($0.0001 par value) |
S - Sale | -3.235 | 0 | -100,00 | 4,20 | -13.593 | ||
2012-05-17 |
|
4 | MXL |
MAXLINEAR INC
Class B Common Stock (convertible into Class A Common Stock) |
C - Conversion | -1.640 | 13.258 | -11,01 | ||||
2012-05-17 |
|
4 | MXL |
MAXLINEAR INC
Class B Common Stock (convertible into Class A Common Stock) |
C - Conversion | -3.235 | 26.154 | -11,01 | ||||
2012-05-17 |
|
4 | MXL |
MAXLINEAR INC
Class B Common Stock (convertible into Class A Common Stock) |
C - Conversion | -3.378 | 27.314 | -11,01 | ||||
2012-05-17 |
|
4 | MXL |
MAXLINEAR INC
Class B Common Stock (convertible into Class A Common Stock) |
C - Conversion | -350.000 | 2.829.845 | -11,01 | ||||
2012-05-17 |
|
4 | MXL |
MAXLINEAR INC
Class A Common Stock ($0.0001 par value) |
J - Other | -3.378 | 0 | -100,00 | ||||
2012-05-17 |
|
4 | MXL |
MAXLINEAR INC
Class A Common Stock ($0.0001 par value) |
J - Other | -350.000 | 0 | -100,00 | ||||
2012-05-17 |
|
4 | MXL |
MAXLINEAR INC
Class A Common Stock ($0.0001 par value) |
C - Conversion | 1.640 | 1.640 | |||||
2012-05-17 |
|
4 | MXL |
MAXLINEAR INC
Class A Common Stock ($0.0001 par value) |
C - Conversion | 3.235 | 3.235 | |||||
2012-05-17 |
|
4 | MXL |
MAXLINEAR INC
Class A Common Stock ($0.0001 par value) |
C - Conversion | 3.378 | 3.378 | |||||
2012-05-17 |
|
4 | MXL |
MAXLINEAR INC
Class A Common Stock ($0.0001 par value) |
C - Conversion | 350.000 | 350.000 | |||||
2012-05-15 |
|
4 | IMI |
INTERMOLECULAR INC
Common Stock, $0.001 per share |
J - Other | -537.600 | 4.839.119 | -10,00 | ||||
2012-04-25 |
|
4 | GWRE |
Guidewire Software, Inc.
Common Stock |
S - Sale | -15.860 | 43.843 | -26,56 | 28,25 | -448.045 | 1.238.565 | |
2012-04-25 |
|
4 | GWRE |
Guidewire Software, Inc.
Common Stock |
S - Sale | -29.561 | 81.720 | -26,56 | 28,25 | -835.098 | 2.308.590 | |
2012-04-25 |
|
4 | GWRE |
Guidewire Software, Inc.
Common Stock |
S - Sale | -23.250 | 64.270 | -26,57 | 28,25 | -656.812 | 1.815.628 | |
2012-04-25 |
|
4 | GWRE |
Guidewire Software, Inc.
Common Stock |
S - Sale | -3.155.311 | 8.722.862 | -26,56 | 28,25 | -89.137.536 | 246.420.852 | |
2012-01-30 |
|
4 | GWRE |
Guidewire Software, Inc.
Series C Convertible Preferred Stock |
C - Conversion | -4.886 | 0 | -100,00 | ||||
2012-01-30 |
|
4 | GWRE |
Guidewire Software, Inc.
Series C Convertible Preferred Stock |
C - Conversion | -9.107 | 0 | -100,00 | ||||
2012-01-30 |
|
4 | GWRE |
Guidewire Software, Inc.
Series C Convertible Preferred Stock |
C - Conversion | -7.163 | 0 | -100,00 | ||||
2012-01-30 |
|
4 | GWRE |
Guidewire Software, Inc.
Series C Convertible Preferred Stock |
C - Conversion | -972.110 | 0 | -100,00 | ||||
2012-01-30 |
|
4 | GWRE |
Guidewire Software, Inc.
Series B Convertible Preferred Stock |
C - Conversion | -9.460 | 0 | -100,00 | ||||
2012-01-30 |
|
4 | GWRE |
Guidewire Software, Inc.
Series B Convertible Preferred Stock |
C - Conversion | -17.632 | 0 | -100,00 | ||||
2012-01-30 |
|
4 | GWRE |
Guidewire Software, Inc.
Series B Convertible Preferred Stock |
C - Conversion | -13.868 | 0 | -100,00 | ||||
2012-01-30 |
|
4 | GWRE |
Guidewire Software, Inc.
Series B Convertible Preferred Stock |
C - Conversion | -1.882.117 | 0 | -100,00 | ||||
2012-01-30 |
|
4 | GWRE |
Guidewire Software, Inc.
Series A Convertible Preferred Stock |
C - Conversion | -43.981 | 0 | -100,00 | ||||
2012-01-30 |
|
4 | GWRE |
Guidewire Software, Inc.
Series A Convertible Preferred Stock |
C - Conversion | -81.976 | 0 | -100,00 | ||||
2012-01-30 |
|
4 | GWRE |
Guidewire Software, Inc.
Series A Convertible Preferred Stock |
C - Conversion | -64.475 | 0 | -100,00 | ||||
2012-01-30 |
|
4 | GWRE |
Guidewire Software, Inc.
Series A Convertible Preferred Stock |
C - Conversion | -8.750.236 | 0 | -100,00 | ||||
2012-01-30 |
|
4 | GWRE |
Guidewire Software, Inc.
Common Stock |
C - Conversion | 58.327 | 59.703 | 4.238,88 | ||||
2012-01-30 |
|
4 | GWRE |
Guidewire Software, Inc.
Common Stock |
C - Conversion | 108.715 | 111.281 | 4.236,75 | ||||
2012-01-30 |
|
4 | GWRE |
Guidewire Software, Inc.
Common Stock |
C - Conversion | 85.506 | 87.520 | 4.245,58 | ||||
2012-01-30 |
|
4 | GWRE |
Guidewire Software, Inc.
Common Stock |
C - Conversion | 11.604.463 | 11.878.173 | 4.239,69 | ||||
2012-01-24 | 3 | GWRE |
Guidewire Software, Inc.
Common Stock |
273.710 | ||||||||
2012-01-24 | 3 | GWRE |
Guidewire Software, Inc.
Common Stock |
2.014 | ||||||||
2012-01-24 | 3 | GWRE |
Guidewire Software, Inc.
Common Stock |
2.566 | ||||||||
2012-01-24 | 3 | GWRE |
Guidewire Software, Inc.
Common Stock |
1.376 |